The University of Queensland Diamantina Institute has secured a $2 million grant from the Australian Cancer Research Foundation for a new cancer treatment centre in Brisbane.
7 November 2013The influence of genes on body mass index scores is substantially lower than previously thought, researchers at The University of Queensland have found.
31 October 2013A vaccine against cervical cancer, a global parenting program, new forms of pain relief, better yielding crops and improved medical imaging are some of many high-impact outcomes of University of Queensland research.
19 September 2013A University of Queensland spin-off company is about to start clinical trials that could result in the prevention and treatment of genital herpes, a virus that affects hundreds of thousands of people, threatens newborn babies and is believed to...
2 July 2013A worldwide consortium of medical researchers and social scientists has found tiny changes to a person's genetic sequence are associated with educational level.
30 May 2013Two researchers from The University of Queensland have been named finalists in one of Australia’s longest running and most prestigious medical research awards: the GlaxoSmithKline Awards for Research Excellence.
31 July 2012The University of Queensland Diamantina Institute's Dr Michelle Hill has been announced a winner of a Australian Research Council (ARC) Future Fellowship to study the total cellular effect of cancer-associated changes in cellular membranes.
31 July 2012In a world first, Australian schoolboys will be able to receive the Gardasil vaccine, protecting them against developing a range of cancers - a move which will improve the effectiveness of the vaccine in women.
13 July 2012An international collaboration involving the development of next-generation of smart medicines in Brisbane has received a boost, with $485,000 in State Government funding
19 June 2012The University of Queensland Diamantina Institute’s researchers have played a leading role in a recent study into osteoporosis, more than doubling the number of currently known genes in the disease.
27 April 2012The vision of a specialised centre to better understand and treat head and neck cancers will come to fruition — thanks to $15 million funding from Atlantic Philanthropies, the Queensland Government and the Princess Alexandra Hospital.
9 March 2012Since 2005, genome-wide association studies (GWAS) have successfully identified thousands of genes responsible for common human diseases.
13 January 2012Professor Ian Frazer, who was named Australian of the Year in 2006 for his development of the human papillomavirus (HPV) cervical cancer vaccines, has become one of the most recent members of the Australian Academy of Science, alongside a Nobel...
14 December 2011University of Queensland Diamantina Institute (UQDI) researcher Professor Ranjeny Thomas has been named as a finalist in the Health category of the Australian Innovation Challenge Awards for her development of a rheumatoid arthritis vaccine.
7 December 2011A University of Queensland (UQ) start-up company, Coridon Pty Ltd, established to commercialise Professor Ian Frazer’s work in developing next generation DNA vaccines, has successfully completed pre-clinical efficacy testing of its prototype Herpes...
24 October 2011A PhD student from The University of Queensland Diamantina Institute (UQDI), is one of six state winners of the AusBiotech/GSK Student Excellence Awards.
12 October 2011Two University of Queensland researchers have been chosen as part of an expert panel to conduct an independent review on health and medical research in Australia.
27 September 2011A cancer genomics facility set to revolutionise cancer research will be unveiled at The University of Queensland Diamantina Institute (UQDI) on Tuesday, July 19.
15 July 2011Co-creator of the cervical cancer vaccine Professor Ian Frazer has just finished a two-and-a-half-week tour of South-East Asia in an effort to promote and showcase Australian scientific research.
1 June 2011The Human Genetics team at The University of Queensland Diamantina Institute have successfully used a new gene-mapping approach for patients affected by severe skeletal abnormalities.
4 May 2011- 1 of 2
- next ›